未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Electroacupuncture for motor dysfunction and constipation in patients with Parkinson?s disease: a randomised controlled multi-centre trial Li, Kunshan; Xu, Shifen; Wang, Ruiping; Zou, Xuan; Liu, Huirong; Fan, Chunhai; Li, Jing; Li, Guona; Wu, Yiwen; Ma, Xiaopeng; Chen, Yiyi; Hu, Chenfang; Liu, Xiru; Yuan, Canxing; Ye, Qing; Dai, Ming; Wu, Luyi; Wang, Zhaoqin; Wu, Huangan 分享 收藏
分享 收藏
分享 收藏
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib plus capecitabine (N plus C) vs lapatinib plus capecitabine (L plus C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens NALA试验中泛亚洲患者亚组的分析: 一项随机III期NALA试验,比较了HER2转移性乳腺癌 (mBC) 患者中奈拉替尼加卡培他滨 (N加C) 与拉帕替尼加卡培他滨 (L加C) 先前接受过两种或多种HER2-directed方案治疗的患者 Dai, Ming Shen; Feng, Yin Hsun; Chen, Shang Wen; Masuda, Norikazu; Yau, Thomas; Chen, Shou Tung; Lu, Yen Shen; Yap, Yoon Sim; Ang, Peter C. S.; Chu, Sung Chao; Kwong, Ava; Lee, Keun Seok; Ow, Samuel; Kim, Sung Bae; Lin, Johnson; Chung, Hyun Cheol; Ngan, Roger; Kok, Victor C.; Rau, Kun Ming; Sangai, Takafumi; Ng, Ting Ying; Tseng, Ling Ming; Bryce, Richard; Bebchuk, Judith; Chen, Mei Chieh; Hou, Ming Feng 分享 收藏
分享 收藏
Neratinib plus capecitabine (N plus C) vs lapatinib plus capecitabine (L plus C) in Asians with HER2+metastatic breast cancer (MBC) previously treated with two or more HER2-directed regimens: A Pan-Asian analysis of the phase III NALA trial Dai, M. S.; Feng, Y. H.; Chen, S. W.; Masuda, N.; Sangai, T.; Yau, T.; Kwong, A.; Ngan, R.; Yap, Y. S.; Ang, P. C. S.; Ow, S.; Lee, K. S.; Kim, S. B.; Chung, H. C.; Keyvanjah, K.; Bebchuk, J.; Chen, M-C. J. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏